Robert Lufkin: Anti-Amyloid Drugs Fail Alzheimer’s Patients
Robert Lufkin, Advisor of Metabolic Health and Longevity Expert, shared post on LinkedIn:
“A Cochrane review of 17 trials and 20,342 patients concluded anti-amyloid drugs offer no clinically meaningful benefit for Alzheimer’s.
As a medical school professor, I have watched the amyloid hypothesis dominate Alzheimer’s research for 30 years.
Findings:
- 17 trials, 20,342 patients
- Effects on cognitive decline absent or trivial
- The drugs remove amyloid but raise brain bleeding and swelling risk
- Authors call for research on other mechanisms
Lead author Dr. Francesco Nonino:
‘These drugs make no meaningful difference to patients.’
This is the textbook story I called out in ‘Lies I Taught in Medical School.’
The amyloid hypothesis was elegant.
As a target, it was wrong.
Growing evidence points to Alzheimer’s as a metabolic disease – driven by insulin resistance, glucose hypometabolism, and mitochondrial dysfunction.
Metabolic dysfunction is the root cause of chronic disease.
Full breakdown coming on the Health Longevity Secrets podcast.
View Cochrane review.”

Stay updated on all scientific advances with Hemostasis Today.
-
Jun 13, 2026, 12:50Cornelia Englisch: Insights Into Clonal Hematopoiesis and Thrombosis Risk at EHA 2026
-
Jun 13, 2026, 11:18Mavis Agnes Kisakye: Transforming Lives Through the WFH Humanitarian Aid Program in Uganda
-
Jun 13, 2026, 10:48Humberto Cruz Esparra: Stroke Recovery Is More Than Regaining Function
-
Jun 13, 2026, 10:43Karina Sultankulova: Smarter D-Dimer Strategies for Safe and Efficient DVT Exclusion
-
Jun 13, 2026, 10:34Kelvin Hill: The Updated Stroke Clinical Care Standard Is Out Now
-
Jun 13, 2026, 10:04Johanna Gebhart: New Publication from the Vienna Bleeding Biobank Advancing BDUC Research Is Now Live
-
Jun 13, 2026, 08:50Alfadil Haroon: Decoding the Complexity of Factor II Deficiency at EHA 2026
-
Jun 13, 2026, 08:44Omid Seidizadeh: Honored to Present on Advances in VWD Management at EHA 2026
-
Jun 13, 2026, 02:23Ruben Mesa: Honoring MPN Legend Prof. Claire Harrison